Adjuvant therapy for patients with high-risk malignant melanoma☆
To access this article, please choose from the options below
☆ Address reprint requests to Edward F. McClay, MD, Melanoma Research Center of San Diego, 910 Sycamore Aue, Suite 102, Vista, CA 92083.
PII: S0093-7754(02)50269-4
doi:10.1053/sonc.2002.34118
© 2002 Published by Elsevier Inc.
